Sai Parenteral's IPO
Sai Parenteral's IPO is listed on BSE and NSE, priced at ₹372–₹392 per share. The stock debuted at ₹400, delivering a listing gain of 2.0%. The IPO had a lot size of ₹38 shares and a minimum investment of ₹14,896.
Sai Parenteral's Limited IPO
- IPO Dates
- Mar 24, 2026 – Mar 27, 2026
- Price band
- ₹372-392 per equity share
- Minimum Investment
- ₹14,896
- Issue size
- ₹408.79 Cr
- Lot size
- 38
- Allotment Date
- Mar 30, 2026
- Listing
- Apr 2, 2026
- Listing At
- BSE, NSE
IPO timeline
-
Mar 24, 2026
Open Date
Completed
-
Mar 27, 2026
Close Date
Completed
-
Mar 30, 2026
Allotment Date
Completed
-
Apr 2, 2026
Listing Date
Completed
Price Summary
- Last closing
- 488.00 (24.49%)
- 52 week high
- 526.30
- 52 week low
- 400.00
- Last update
Sai Parenteral's IPO Subscription Details
View Subscription DetailsSai Parenteral's IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.
Last updated:Sai Parenteral's IPO Essentials
Sai Parenteral's IPO Details
Sai Parenteral's IPO is priced at ₹372-392 per share with a total issue size of 408.79 crore. The IPO has a lot size of 38 shares and is listed on a BSE and NSE.
- Issue price
- ₹372-392 per equity share
- Lot size
- 38 shares
- Face value
- ₹5 Per Equity Share
- Issue size
- ₹408.79 Crores
- Total issue size
- 1,04,28,288 shares
(aggregating up to ₹408.79 crore) - Fresh issue
- 72,70,408 shares
(aggregating up to ₹285 crore) - Offer for sale (OFS)
- 31,57,880 shares
(aggregating up to ₹123.79 crore) - Listing at
- BSE, NSE
- List price
- 400.0(NSE)
- Listing date
- Registrar
- Bigshare Services Pvt.Ltd.
- Lead manager
-
Arihant Capital Markets Ltd.
Market Lot Size
Investors can bid for a minimum of 38 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 38 | ₹14,896 |
| Retail(max) | 13 | 494 | ₹1,93,648 |
| sHNI(min) | 14 | 532 | ₹2,08,544 |
| sHNI(max) | 67 | 2,546 | ₹9,98,032 |
| sHNI(min) | 68 | 2,584 | ₹10,12,928 |
Sai Parenteral's IPO Reservation
Sai Parenteral's IPO reservation details show category-wise allocation of shares. Out of the total 10428288 shares, approximately 20% are reserved for QIB, 15% for NII, 35% for retail investors, and 30% for anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 3128485 (30%) | |
| QIB Shares Offered | 2085659 (20%) | |
| NII (HNI) Shares Offered | 1564243 (15%) | |
| bHNI > ₹10L | 1042829 (10%) | 1960 |
| sHNI < ₹10L | 521414 (5%) | 980 |
| Retail Shares Offered | 3649901 (35%) | 96,050 |
| Total Shares Offered | 10428288 (100%) |
Sai Parenteral's IPO Analytics
Sai Parenteral's IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Sai Parenteral's IPO Subscription Status
Sai Parenteral's IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO is currently subscribed 1.08x, indicating moderate demand across investor categories.
| As on | QIB |
NII
bHNI
sHNI
|
Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 20,85,659 |
15,64,243
10,42,829
5,21,414
|
36,49,901 | 72,99,803 |
|
Day 1
24-03-26 05:00 PM
|
0.00 x |
0.15x
0.22x
0.03x
|
0.03 x | 0.05 x |
|
Day 2
25-03-26 05:00 PM
|
0.60 x |
1.05x
1.55x
0.04x
|
0.05 x | 0.42 x |
|
Day 3
27-03-26 05:00 PM
|
1.73 x |
2.45x
3.56x
0.24x
|
0.12 x | 1.08 x |
|
Total No. of Applications
|
bHNI | sHNI | Retail |
|---|---|---|---|
| 8166 (Approx) | 0.08x | 0.13x | 0.08x |
Sai Parenteral's Valuations
Earnings
- EPS Pre IPO
- ₹5.43/-
- P/E Pre IPO
- 72.19
Returns
- ROE
- 16.82%
- ROCE
- 28.92%
- RoNW
- 15.09%
- PAT Margin
- 8.88%
Fundamentals
- Price / Book
- 10.89
- Market Cap
- 1,731.83 Cr.
Sai Parenteral's Financials( In Crs.)
| 30-Sep-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|---|
| Assets | 376.24 | 272.39 | 268.10 | 133.96 |
| Revenue | 89.43 | 163.74 | 155.18 | 97.03 |
| Profit After Tax | 7.76 | 14.43 | 8.42 | 4.38 |
| Net Worth | 209.37 | 95.78 | 76.40 | 31.49 |
| Reserves & Surplus | 188.84 | 80.36 | 61.30 | 24.34 |
| Total Borrowing | 76.07 | 93.95 | 118.79 | 68.55 |
Sai Parenteral's Company & Offer Insights
About Sai Parenteral's
Established in 2001, Sai Parenteral's Ltd. is a diversified pharmaceutical formulations company with expertise in research and development and manufacturing.
The company has two business segments: Branded Generic Formulations and Contract Development and Manufacturing Organisation (CDMO) products and services.
The company’s product portfolio covers a wide spectrum of pharmaceutical formulations in various therapeutic areas such as cardiovascular, neuropsychiatry, anti-diabetic agents, respiratory health, antibiotics, gastroenterology, vitamins, minerals, and supplements (VMS), analgesics, and dermatology in various dosage forms such as injectables, tablets, capsules, liquid orals, and ointments.
The company’s customer base comprises central and state government departments, pharmaceutical companies, public and private sector hospitals, and super stockists across India. Sai Parenteral’s started its export business in FY 2023 after acquiring two international accredited facilities in Hyderabad, Telangana, and currently serves regulated and semi-regulated markets such as Australia, New Zealand, Southeast Asia, Middle East, and Africa.
The company has five manufacturing facilities in India. Four are located in Hyderabad, Telangana. These are a GMP compliant injectable facility, a WHO-GMP injectable facility, a TGA-Australia and PIC/S accredited solid oral dosage facility, and a WHO-GMP cephalosporin facility. The company’s wholly owned subsidiary has a GMP certified facility located in Ongole, Andhra Pradesh.
As of August 31, 2025, Sai Parenteral's Ltd. had 277 full-time employees.
Sai Parenteral's Promoter(s)
Anil Kumar Karusala, Vijitha Gorrepati, Karusala Aruna are the company's promoters of Sai Parenteral's.
Sai Parenteral's IPO Issue Objectives
- •
- Capacity expansion and upgradation of manufacturing facilities - ₹110.80 Crores
- •
- Establishment of a new R&D Centre - ₹18.02 Crores
- •
- Repayment / prepayment of certain outstanding borrowings - ₹14.30 Crores
- •
- Working capital requirements - ₹33.00 Crores
- •
- Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia) - ₹35.64 Crores
- •
- General corporate purposes
Sai Parenteral's IPO - Anchor Investors
Sai Parenterals raises Rs 123 crore via anchor book ahead of IPO.
Out of the total allocation, 9.18 lakh shares worth Rs 36 crore were allocated to one domestic mutual fund, namely Quant Mutual Fund, and 7.65 lakh shares worth Rs 30 crore to one insurance company, namely Kotak Mahindra Life Insurance Company.
Kotak Life Sciences Fund also subscribed to 7.65 lakh shares worth nearly Rs 30 crore, followed by Morgan Stanley Asia (Singapore), and India Emerging Giants Fund, which acquired 3.82 lakh shares worth Rs 15 crore and 2.96 lakh shares worth Rs 11.63 crore, respectively.
Sai Parenteral's IPO - Strengths and Risks
Sai Parenteral's IPO strengths and risks highlight key business factors, financial position, and market sentiment that may impact investor interest.
Strengths
Risks
Contact Information
Contact Details
Sai Parenteral's
+91 79979 91301
Plot No 39, 5th Floor, Lavanya Arcade, Jayabheri Enclave, Gachibowli, K.V. Rangareddy, Seri Lingampally, Hyderabad, Telangana - 500032.
Registrar Contact Details
Bigshare Services Pvt Ltd
+91-22-6263 8200
Frequently Asked Questions
Click any question to reveal the answer
Sai Parenteral's IPO is a book-built IPO worth ₹408.79 crore. The price band is ₹372–₹392 per share. The IPO opens on Mar 24, 2026 and closes on Mar 27, 2026. It will be listed on BSE and NSE. Bigshare Services Pvt. Ltd. is the registrar.
The price band of Sai Parenteral's IPO is ₹372 to ₹392 per share.
The lot size of Sai Parenteral's IPO is 38 shares.
The minimum investment for Sai Parenteral's IPO is approximately ₹14,896 based on the upper price band .
Sai Parenteral's IPO opens on Mar 24, 2026 and closes on Mar 27, 2026.
The allotment date of Sai Parenteral's IPO is Mar 30, 2026.
Sai Parenteral's IPO is expected to be listed on Apr 2, 2026, on BSE and NSE .
Sai Parenteral's IPO listed on Apr 2, 2026. It was issued at ₹400.0(NSE) and is currently around ₹488.00 as on 30-Apr-2026 3:30 PM, which is approximately 24.5% versus issue price. The 52-week high is ₹526.30.
Based on listing and post-listing performance, Sai Parenteral's IPO delivered around 24.5% over issue price. Whether it was worth applying depends on your risk profile, allocation, and holding horizon.
To buy Sai Parenteral's IPO shares after listing, log in to your broker app (such as Zerodha, Angel One, Groww, Upstox, ICICI Direct), search the stock symbol, place a delivery/CNC order, and confirm quantity and price.
Sai Parenteral's IPO valuation snapshot: P/E N/A, EPS ₹/-, P/B 10.89, RoNW 15.09%, and market cap 1,731.83 Cr.
To apply for Sai Parenteral's IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Sai Parenteral's IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Sai Parenteral's IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Sai Parenteral's IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Sai Parenteral's IPO allotment status on IPO Ji for quick and easy access.